Lesley Saketkoo
Rheumatology · New Orleans, LANPI 1144253931
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $58,850 of the $97,073 with a category attached, or 60.6%. Actelion Pharmaceuticals US, Inc. accounts for 64.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $28,722 and has fallen 98.3% since, to $478 in 2025.
Across 114 payments — averaging $851.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$63K
- Boehringer Ingelheim$16K
- Boehringer Ingelheim International GmbH$10K
- AbbVie$3K
- Argenx US, Inc.$3K
- Mallinckrodt Hospital Products Inc.$356
- plus $566 from 9 others
Across 41 payments — averaging $4791.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$124K
- Boehringer Ingelheim$53K
- Sanofi US Services Inc.$16K
- Kadmon Corporation LLC$2K
- Boehringer Ingelheim Pharma GmbH & Co.kg$1K
- Argenx US, Inc.$235
What the payments were for
- Consulting fees$27,91029%
- Speaking & faculty fees$58,85061%
- Travel & lodging$7,3748%
- Food & beverage$2,9213%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 59 | $62,982 |
| Boehringer Ingelheim | 17 | $16,285 |
| Boehringer Ingelheim International GmbH | 15 | $10,400 |
| AbbVie | 2 | $3,300 |
| Argenx US, Inc. | 3 | $3,184 |
| Mallinckrodt Hospital Products Inc. | 3 | $356 |
| EMD Serono, Inc. | 2 | $178 |
| Mallinckrodt Enterprises LLC | 2 | $125 |
| Johnson & Johnson | 4 | $57 |
| United Therapeutics Corporation | 1 | $56 |
| GSK | 1 | $50 |
| Genentech USA, Inc. | 2 | $33 |
| Amgen | 1 | $30 |
| Octapharma USA, Inc. | 1 | $20 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$97,073 in reported general payments places this provider in the 85th percentile of 88 rheumatology providers in Louisiana.
Other rheumatology in New Orleans
- Evangeline ScopelitisNew Orleans$96K
- William DavisNew Orleans$37K
- Barrett FordNew Orleans$16K
- Luis EspinozaNew Orleans$11K
- Mansour AlghamdiNew Orleans$9K
- Nirupa PatelNew Orleans$7K
- Laura RiversNew Orleans$6K
- Shreya MadhavaramNew Orleans$5K
- Aaron BroadwellShreveport$1.6M
- Ladislas LazaroLafayette$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.